
    
      Treatment of arterial ulcers is problematic. Previous pharmaceutical interventions with for
      example prostaglandins have produced only limited beneficial effects but have been associated
      with frequent adverse effects. Positive effects of isoniazid have been observed in a
      preclinical model of ischemic wound healing (Weinreich et al. Surgery 2010).
    
  